Profiel
Dr. Alejandro Dorenbaum, MD, is a Chief Medical Officer at Reneo Pharmaceuticals, Inc. and a Clinical Professor-Pediatrics at Stanford University School of Medicine.
Dr. Dorenbaum was previously employed as a Chief Medical Officer by Allakos, Inc., a Chief Medical Officer by Lumena Pharmaceuticals, Inc., a Medical Director by Genentech, Inc., a Senior Director-Clinical Affairs by BioMarin Pharmaceutical, Inc., a Director-Clinical Development by Chiron Corp., and an Assistant Clinical Professor-Pediatrics by The University of California, San Francisco.
He received his doctorate degree from Universidad Nacional Autónoma de México.
Actieve functies van Alejandro Dorenbaum
| Bedrijven | Functie | Begin |
|---|---|---|
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Alejandro Dorenbaum
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLAKOS INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2017 |
Lumena Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for rare liver diseases | Hoofd Techniek/Wetenschap/O&O | 30-06-2014 |
| BIOMARIN PHARMACEUTICAL INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2009 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 01-01-2003 |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2000 |
Opleiding van Alejandro Dorenbaum
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Lumena Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for rare liver diseases | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad Nacional Autónoma de México
Universidad Nacional Autónoma de México Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allakos, Inc.
Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
















